置換液の安全性(<特集>アフェレシスにおけるセイフティーマネジメント)  [in Japanese] Safety of Displacement Liquid for Plasma Exchange Therapy  [in Japanese]

    • 比留間 潔 Hiruma Kiyoshi
    • 東京都立駒込病院輸血・細胞治療科 The Division of Transfusion Service and Cell Therapy, Tokyo Metropolitan Komagome Hospital

Abstract

Fresh frozen plasma (FFP) is used as displacement liquid for plasma exchange therapy in the cases requiring some coagulation factors and other plasma factors, whereas albumin products should be selected in the cases requiring only to maintain the colloid osmotic pressure of blood. Although FFP may be considered to be safe as to transfusion-transmitted disease, immunological adverse events such as transfusion-related lung injury (TRALI) or alloimmunization should be kept in mind. Albumin products are safer than FFP because they are treated with various pathogen inactivation procedures and have few alloantigens. Therefore, albumin products should be used for displacement liquid in plasma exchange therapy as far as possible.

Journal

Japanese journal of apheresis   [List of Volumes]

Japanese journal of apheresis 24(1), 20-23, 2005-02-28  [Table of Contents]

Japanese Society for Apheresis

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110003161374
  • NII NACSIS-CAT ID (NCID) :
    AA11604174
  • Text Lang :
    JPN
  • ISSN :
    13405888
  • Databases :
    NII-ELS